OneSource Specialty Pharma Past Earnings Performance
Past criteria checks 0/6
OneSource Specialty Pharma has been growing earnings at an average annual rate of 106.3%, while the Life Sciences industry saw earnings growing at 19.2% annually. Revenues have been growing at an average rate of 61.7% per year.
How OneSource Specialty Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
NSEI:ONESOURCE Revenue, expenses and earnings (INR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
14,366
-738
2,423
0
31 Dec 25
14,193
208
2,537
0
30 Sep 25
15,215
406
2,469
0
30 Jun 25
14,798
-119
2,208
0
31 Mar 25
14,449
-173
2,324
0
31 Dec 24
10,920
-1,566
1,878
0
30 Jun 24
2,415
-3,207
849
0
31 Mar 24
1,719
-3,657
826
0
31 Mar 23
387
-4,156
749
0
Quality Earnings: ONESOURCE is currently unprofitable.
Growing Profit Margin: ONESOURCE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ONESOURCE's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ONESOURCE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ONESOURCE is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (9.9%).
Return on Equity
High ROE: ONESOURCE has a negative Return on Equity (-1.27%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/30 03:17
End of Day Share Price
2026/05/29 00:00
Earnings
2026/03/31
Annual Earnings
2026/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
OneSource Specialty Pharma Limited is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.